(-)-epigallocatechin 3-gallate multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DOCK9 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression ISO Dock9 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of DOCK9 mRNA CTD PMID:22206623 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of DOCK9 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO DOCK9 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DOCK9 mRNA CTD PMID:21215274 and PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DOCK9 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-tribromophenol decreases expression ISO DOCK9 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of DOCK9 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO DOCK9 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of DOCK9 mRNA CTD PMID:30851411 2-palmitoylglycerol increases expression ISO DOCK9 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of DOCK9 mRNA CTD PMID:37199045 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Dock9 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of DOCK9 protein CTD PMID:34915118 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of DOCK9 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases methylation ISO DOCK9 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of DOCK9 gene CTD PMID:31601247 4,4'-sulfonyldiphenol affects methylation ISO Dock9 (Mus musculus) 6480464 bisphenol S affects the methylation of DOCK9 gene CTD PMID:31683443 4-hydroxyphenyl retinamide decreases expression ISO Dock9 (Mus musculus) 6480464 Fenretinide results in decreased expression of DOCK9 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of DOCK9 mRNA CTD PMID:24780913 7,12-dimethyltetraphene decreases expression ISO Dock9 (Mus musculus) 6480464 9 more ... CTD PMID:32553695 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of DOCK9 mRNA CTD PMID:31881176 acrolein multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DOCK9 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DOCK9 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO Dock9 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of DOCK9 mRNA CTD PMID:19770486 aflatoxin B1 affects methylation ISO DOCK9 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of DOCK9 intron CTD PMID:30157460 aflatoxin B1 increases methylation ISO DOCK9 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of DOCK9 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO Dock9 (Mus musculus) 6480464 Tretinoin results in increased expression of DOCK9 mRNA CTD PMID:16788091 all-trans-retinoic acid increases expression ISO DOCK9 (Homo sapiens) 6480464 Tretinoin results in increased expression of DOCK9 mRNA CTD PMID:21934132 alpha-pinene multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DOCK9 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DOCK9 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DOCK9 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO DOCK9 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of DOCK9 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO DOCK9 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of DOCK9 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO DOCK9 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to DOCK9 mRNA] CTD PMID:32406909 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of DOCK9 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO Dock9 (Mus musculus) 6480464 Benzo(a)pyrene metabolite results in decreased expression of DOCK9 mRNA and Benzo(a)pyrene results in decreased expression of DOCK9 mRNA CTD PMID:19770486 more ... benzo[a]pyrene decreases methylation ISO Dock9 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of DOCK9 exon and Benzo(a)pyrene results in decreased methylation of DOCK9 intron CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO DOCK9 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene decreases methylation ISO DOCK9 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of DOCK9 intron CTD PMID:30157460 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DOCK9 mRNA CTD PMID:18164116 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of DOCK9 mRNA CTD PMID:15651846 bis(2-ethylhexyl) phthalate increases expression ISO DOCK9 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of DOCK9 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DOCK9 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DOCK9 gene CTD PMID:31601247 bisphenol A increases expression ISO DOCK9 (Homo sapiens) 6480464 bisphenol A results in increased expression of DOCK9 mRNA CTD PMID:33670352 bisphenol A decreases methylation ISO Dock9 (Mus musculus) 6480464 bisphenol A results in decreased methylation of DOCK9 promoter CTD PMID:27312807 butanal decreases expression ISO DOCK9 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of DOCK9 mRNA CTD PMID:26079696 carbon nanotube decreases expression ISO Dock9 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of DOCK9 mRNA CTD PMID:25554681 cobalt dichloride decreases expression ISO DOCK9 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of DOCK9 mRNA CTD PMID:19320972 crocidolite asbestos increases expression ISO DOCK9 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of DOCK9 mRNA CTD PMID:25351596 crocidolite asbestos decreases expression ISO Dock9 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of DOCK9 mRNA CTD PMID:29279043 decabromodiphenyl ether increases expression ISO DOCK9 (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of DOCK9 protein CTD PMID:31675489 dorsomorphin multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO DOCK9 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of DOCK9 mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO Dock9 (Mus musculus) 6480464 epoxiconazole results in decreased expression of DOCK9 mRNA CTD PMID:35436446 formaldehyde increases expression ISO DOCK9 (Homo sapiens) 6480464 Formaldehyde results in increased expression of DOCK9 mRNA CTD PMID:23649840 FR900359 affects phosphorylation ISO DOCK9 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of DOCK9 protein CTD PMID:37730182 fulvestrant multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DOCK9 gene CTD PMID:31601247 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of DOCK9 mRNA CTD PMID:24136188 glyphosate increases methylation EXP 6480464 Glyphosate results in increased methylation of DOCK9 gene CTD PMID:31011160 inulin multiple interactions ISO Dock9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of DOCK9 mRNA CTD PMID:36331819 isoprenaline increases expression ISO Dock9 (Mus musculus) 6480464 Isoproterenol results in increased expression of DOCK9 mRNA CTD PMID:20003209 lead(0) affects expression ISO DOCK9 (Homo sapiens) 6480464 Lead affects the expression of DOCK9 mRNA CTD PMID:28903495 mercury dibromide increases expression ISO DOCK9 (Homo sapiens) 6480464 mercuric bromide results in increased expression of DOCK9 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK9 mRNA CTD PMID:27188386 methapyrilene decreases methylation ISO DOCK9 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of DOCK9 intron CTD PMID:30157460 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of DOCK9 mRNA CTD PMID:30467583 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of DOCK9 gene CTD PMID:35440735 methylmercury chloride decreases expression ISO DOCK9 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of DOCK9 mRNA CTD PMID:23179753 and PMID:28001369 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of DOCK9 gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DOCK9 mRNA CTD PMID:18164116 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of DOCK9 mRNA CTD PMID:24136188 nickel atom decreases expression ISO DOCK9 (Homo sapiens) 6480464 Nickel results in decreased expression of DOCK9 mRNA CTD PMID:24768652 and PMID:25583101 ozone multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DOCK9 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO Dock9 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DOCK9 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DOCK9 mRNA CTD PMID:27106289 and PMID:34911549 panobinostat increases expression ISO DOCK9 (Homo sapiens) 6480464 panobinostat results in increased expression of DOCK9 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK9 mRNA CTD PMID:27188386 paracetamol increases expression ISO Dock9 (Mus musculus) 6480464 Acetaminophen results in increased expression of DOCK9 mRNA CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DOCK9 mRNA CTD PMID:33387578 pentanal decreases expression ISO DOCK9 (Homo sapiens) 6480464 pentanal results in decreased expression of DOCK9 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO Dock9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of DOCK9 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of DOCK9 mRNA CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of DOCK9 gene CTD PMID:33148267 phenobarbital affects expression ISO Dock9 (Mus musculus) 6480464 Phenobarbital affects the expression of DOCK9 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO DOCK9 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of DOCK9 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK9 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO Dock9 (Mus musculus) 6480464 pirinixic acid results in increased expression of DOCK9 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO DOCK9 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of DOCK9 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DOCK9 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO Dock9 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of DOCK9 mRNA CTD PMID:23608068 rac-lactic acid decreases expression ISO DOCK9 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of DOCK9 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of DOCK9 mRNA CTD PMID:19059307 SB 431542 multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO DOCK9 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of DOCK9 mRNA CTD PMID:25351596 sodium arsenite multiple interactions ISO DOCK9 (Homo sapiens) 6480464 sodium arsenite promotes the reaction [DOCK9 protein binds to CAPRIN1 protein] CTD PMID:33939924 tamoxifen multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of DOCK9 mRNA CTD PMID:19059307 testosterone increases expression ISO DOCK9 (Homo sapiens) 6480464 Testosterone results in increased expression of DOCK9 mRNA CTD PMID:33359661 tetrachloromethane decreases expression ISO Dock9 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of DOCK9 mRNA CTD PMID:17484886 trichostatin A increases expression ISO DOCK9 (Homo sapiens) 6480464 trichostatin A results in increased expression of DOCK9 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK9 mRNA CTD PMID:27188386 trovafloxacin decreases expression ISO Dock9 (Mus musculus) 6480464 trovafloxacin results in decreased expression of DOCK9 mRNA CTD PMID:35537566 valproic acid increases methylation ISO DOCK9 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of DOCK9 gene CTD PMID:29154799 valproic acid multiple interactions ISO DOCK9 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK9 mRNA CTD PMID:27188386 valproic acid increases expression ISO DOCK9 (Homo sapiens) 6480464 Valproic Acid results in increased expression of DOCK9 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO Dock9 (Mus musculus) 6480464 Valproic Acid results in increased expression of DOCK9 mRNA CTD PMID:21427059 vancomycin increases expression ISO Dock9 (Mus musculus) 6480464 Vancomycin results in increased expression of DOCK9 mRNA CTD PMID:18930951